Cargando…
RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells
BACKGROUND: With current treatment strategies, nearly half of all medulloblastoma (MB) patients die from progressive tumors. Accordingly, the identification of novel therapeutic strategies remains a major goal. Deregulation of c-MYC is evident in numerous human cancers. In MB, over-expression of c-M...
Autores principales: | von Bueren, André O, Shalaby, Tarek, Oehler-Jänne, Christoph, Arnold, Lucia, Stearns, Duncan, Eberhart, Charles G, Arcaro, Alexandre, Pruschy, Martin, Grotzer, Michael A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648994/ https://www.ncbi.nlm.nih.gov/pubmed/19134217 http://dx.doi.org/10.1186/1471-2407-9-10 |
Ejemplares similares
-
c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients
por: von Bueren, André O, et al.
Publicado: (2011) -
Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells
por: von Bueren, André O, et al.
Publicado: (2007) -
NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma
por: Fiaschetti, Giulio, et al.
Publicado: (2014) -
Novel Agents Targeting the IGF-1R/PI3K Pathway Impair Cell Proliferation and Survival in Subsets of Medulloblastoma and Neuroblastoma
por: Wojtalla, Anna, et al.
Publicado: (2012) -
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours
por: von Bueren, A O, et al.
Publicado: (2012)